Form 4: Allovir CFO Vikas Sinha Sells Shares to Cover Tax Obligations

Vikas Sinha, CFO of Allovir, sold 303 shares of common stock on February 21, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On February 21, 2025, Vikas Sinha, the President, CFO, and CEO of Allovir, Inc. sold 303 shares of Allovir's common stock.
• The shares were sold at a weighted average price of $10.0758, with individual transactions ranging from $10.06 to $10.13.
• The sale was conducted to cover tax withholding obligations associated with the vesting of restricted stock units and was automatic, not discretionary.
• Following the transaction, Sinha directly owns 49,129 shares and may be deemed to have shared voting and investment power over 724,989 shares held by ElevateBio, where he is a director and CFO.
• Sinha disclaims beneficial ownership of the ElevateBio shares except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: This is a neutral transaction related to tax obligations, not indicative of positive or negative sentiment towards the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders (officers, directors, and those holding more than 10% of the company's shares) buy or sell the company's securities. This filing indicates a routine transaction to cover tax obligations.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the explanation provided (tax obligations) mitigates this concern.

Key Dates